Sanofi Q2 2024 Adj EPS $0.93 Beats $0.86 Estimate, Sales $11.568B Beat $11.366B Estimate
Portfolio Pulse from Benzinga Newsdesk
Sanofi (NASDAQ:SNY) reported Q2 2024 earnings of $0.93 per share, beating the analyst estimate of $0.86. Sales were $11.568 billion, surpassing the $11.366 billion estimate. Despite a 2% decrease in EPS from last year, sales increased by 6.52%.
July 25, 2024 | 5:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sanofi reported Q2 2024 earnings of $0.93 per share, beating the analyst estimate of $0.86. Sales were $11.568 billion, surpassing the $11.366 billion estimate. Despite a 2% decrease in EPS from last year, sales increased by 6.52%.
Sanofi's Q2 2024 earnings and sales both exceeded analyst expectations, which is likely to have a positive short-term impact on the stock price. The increase in sales by 6.52% year-over-year is a strong indicator of growth, despite the slight decrease in EPS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100